January 31, 2022 article Open access Aachen paper

Harmonising patient-access programmes: the Dutch DRUG Access Protocol platform

The Lancet Oncology, vol. 23, pp. 198–201

DOI: 10.1016/s1470-2045(21)00707-5 Full text (OA) OpenAlex

Authors 1

Sahar Barjesteh van Waalwijk van Doorn-Khosrovani

Centraal Ziekenfonds (Netherlands)

Affiliation as printed

CZ Health Insurance, Tilburg, Netherlands

Cited by 24 stored of 25

Merging clinical research and standard healthcare – Nordic Precision Cancer Medicine Symposium 2025
2026 Acta Oncologica article Biochemistry, Genetics and Molecular Biology Cancer Genomics and Diagnostics Open access

0

citations
Stakeholders’ experiences with a clinician-led access programme linking evidence generation and reimbursement for precision cancer treatments: the drug access protocol in the Netherlands
2026 Acta Oncologica article Economics, Econometrics and Finance Pharmaceutical Economics and Policy Open access

2

citations
Access to anticancer and orphan medicines through compassionate use programs and named patient basis in seven European countries
2025 ESMO Open article Economics, Econometrics and Finance Pharmaceutical Economics and Policy Open access

3

citations
Access to EU-Authorized Nonreimbursed Anticancer Medicines: An Explorative Survey Among Dutch Medical Oncologists
2025 Clinical Therapeutics article Economics, Econometrics and Finance Pharmaceutical Economics and Policy Open access

0

citations
Editorial: Towards continued and affordable accessibility of innovative drugs: sustainable development and efficient use of medicines
2024 Frontiers in Pharmacology editorial Economics, Econometrics and Finance Pharmaceutical Economics and Policy Open access

0

citations
Factors affecting the feasibility of post-authorisation RCTs for conditionally authorised anticancer medicines: a multistakeholder perspective from a qualitative focus group study
2024 BMJ Open article Mathematics Statistical Methods in Clinical Trials Open access

4

citations
Empowering effective biomarker-driven precision oncology: A call to action
2024 European Journal of Cancer article Biochemistry, Genetics and Molecular Biology Cancer Genomics and Diagnostics Open access

48

citations
The impact of expanded access programs for systemic anticancer therapy in an Irish cancer centre
2024 Irish Journal of Medical Science (1971 -) article Medicine Biomedical Ethics and Regulation Open access

2

citations
PCM4EU and PRIME-ROSE: Collaboration for implementation of precision cancer medicine in Europe
2024 Acta Oncologica article Biochemistry, Genetics and Molecular Biology Cancer Genomics and Diagnostics Open access

23

citations
Cemiplimab in locally advanced or metastatic cutaneous squamous cell carcinoma: prospective real-world data from the DRUG Access Protocol
2024 The Lancet Regional Health - Europe article Medicine Nonmelanoma Skin Cancer Studies Open access

30

citations
Generating and using real-world data: A worthwhile uphill battle
2024 Cell article Economics, Econometrics and Finance Pharmaceutical Economics and Policy Open access

36

citations
Lessons learned from postmarketing withdrawals of expedited approvals for oncology drug indications
2024 The Lancet Oncology article Economics, Econometrics and Finance Pharmaceutical Economics and Policy

40

citations
Molecular Tumor Boards: On the evolution of species
2024 European Journal of Cancer article Biochemistry, Genetics and Molecular Biology Cancer Genomics and Diagnostics

2

citations
Empowering Effective Biomarker-Driven Precision Oncology a Call to Action
2024 SSRN Electronic Journal preprint Biochemistry, Genetics and Molecular Biology Cancer Genomics and Diagnostics Open access

1

citations
Histology independent drug development – Is this the future for cancer drugs?
2023 Cancer Treatment Reviews article Mathematics Statistical Methods in Clinical Trials Open access

6

citations
How to create value with constrained budgets in oncological care? A narrative review
2023 Expert Review of Pharmacoeconomics & Outcomes Research review Economics, Econometrics and Finance Economic and Financial Impacts of Cancer Open access

1

citations
Precision cancer medicine: Concepts, current practice, and future developments
2023 Journal of Internal Medicine article Biochemistry, Genetics and Molecular Biology Cancer Genomics and Diagnostics Open access

79

citations
Targeted combination therapies in oncology: Challenging regulatory frameworks designed for monotherapies in Europe
2023 Drug Discovery Today article Economics, Econometrics and Finance Pharmaceutical Economics and Policy Open access

8

citations
Real‐world data for precision cancer medicine—A European perspective
2023 Genes Chromosomes and Cancer article Economics, Econometrics and Finance Pharmaceutical Economics and Policy Open access

20

citations
Controversies in the management of patients with soft tissue sarcoma: Recommendations of the Conference on State of Science in Sarcoma 2022
2022 European Journal of Cancer article Medicine Sarcoma Diagnosis and Treatment Open access

26

citations

No patents citing this paper on Lens.org (checked 2026-10-11).

References 7

7 results